163 related articles for article (PubMed ID: 22359289)
1. Epigenetics of bladder cancer.
Kim WJ; Kim YJ
Methods Mol Biol; 2012; 863():111-8. PubMed ID: 22359289
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic markers as promising prognosticators for bladder cancer.
Kim YK; Kim WJ
Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
4. Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
Kim YJ; Kim WJ
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S77-88. PubMed ID: 27326410
[TBL] [Abstract][Full Text] [Related]
5. Identification of epigenetic interactions between miRNA and DNA methylation associated with gene expression as potential prognostic markers in bladder cancer.
Shivakumar M; Lee Y; Bang L; Garg T; Sohn KA; Kim D
BMC Med Genomics; 2017 May; 10(Suppl 1):30. PubMed ID: 28589857
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer.
Dumache R; David D; Kaycsa A; Minciu R; Negru S; Puiu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):163-7. PubMed ID: 21682190
[TBL] [Abstract][Full Text] [Related]
7. Molecular biomarkers in urothelial bladder cancer.
Kim WJ; Bae SC
Cancer Sci; 2008 Apr; 99(4):646-52. PubMed ID: 18377416
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer: biomarker panel predicts recurrence after radical cystectomy.
Payton S
Nat Rev Urol; 2013 Jun; 10(6):309. PubMed ID: 23609843
[No Abstract] [Full Text] [Related]
9. Molecular markers in bladder cancer.
Soria F; Krabbe LM; Todenhöfer T; Dobruch J; Mitra AP; Inman BA; Gust KM; Lotan Y; Shariat SF
World J Urol; 2019 Jan; 37(1):31-40. PubMed ID: 30259123
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic aspects of bladder cancer.
Kim WJ; Quan C
J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
[TBL] [Abstract][Full Text] [Related]
11. Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.
Oliveira AI; Jerónimo C; Henrique R
Expert Rev Mol Diagn; 2012 Nov; 12(8):871-8. PubMed ID: 23249204
[TBL] [Abstract][Full Text] [Related]
12. [Upgrading methods of early detection of recurrent tumors of the bladder].
Aleksandrov VP; Startsev VIu; Koren'kov DG; Karelin MI
Urologiia; 2002; (6):51-5. PubMed ID: 12577582
[No Abstract] [Full Text] [Related]
13. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer biomarkers: review and update.
Ghafouri-Fard S; Nekoohesh L; Motevaseli E
Asian Pac J Cancer Prev; 2014; 15(6):2395-403. PubMed ID: 24761840
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics application in the diagnosis and treatment of bladder cancer.
Harb-de la Rosa A; Acker M; Kumar RA; Manoharan M
Can J Urol; 2015 Oct; 22(5):7947-51. PubMed ID: 26432963
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for bladder cancer aggressiveness.
Frantzi M; Makridakis M; Vlahou A
Curr Opin Urol; 2012 Sep; 22(5):390-6. PubMed ID: 22825458
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer.
McConkey DJ; Choi W; Ochoa A; Siefker-Radtke A; Czerniak B; Dinney CP
Hematol Oncol Clin North Am; 2015 Apr; 29(2):377-94, x-xi. PubMed ID: 25836941
[TBL] [Abstract][Full Text] [Related]
18. Advances in Biomarkers for Detection, Surveillance, and Prognosis of Bladder Cancer.
Henning GM; Barashi NS; Smith ZL
Clin Genitourin Cancer; 2021 Jun; 19(3):194-198. PubMed ID: 33781702
[TBL] [Abstract][Full Text] [Related]
19. [THE SOMATIC MUTATIONS AND ABERRANT METHYLATION AS POTENTIAL GENETIC MARKERS OF URINARY BLADDER CANCER].
Mikhailenko DS; Kushlinskii NE
Klin Lab Diagn; 2016 Feb; 61(2):78-83. PubMed ID: 27455559
[TBL] [Abstract][Full Text] [Related]
20. [Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets].
Mikhailenko DS; Nemtsova MV
Urologiia; 2016 Feb; (1):100-105. PubMed ID: 28247712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
